The iterative process of fluid biomarker development and validation in Alzheimer's disease

Alzheimers Dement (Amst). 2022 Jul 12;14(1):e12341. doi: 10.1002/dad2.12341. eCollection 2022.

Barbara B Bendlin^{1

2

3

4}, Henrik Zetterberg^{5

6

7

8

9}

¹ Center for Health Disparities Research University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA.
² Wisconsin Alzheimer's Disease Research Center University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA.
³ Department of Medicine Geriatrics Division University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA.
⁴ Wisconsin Alzheimer's Institute University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA.
⁵ UK Dementia Research Institute at UCL London UK.
⁶ Department of Neurodegenerative Disease UCL Institute of Neurology London UK.
⁷ Department of Psychiatry and Neurochemistry Institute of Neuroscience and Physiology Sahlgrenska Academy at University of Gothenburg Mölndal Sweden.
⁸ Clinical Neurochemistry Laboratory Sahlgrenska University Hospital Mölndal Sweden.
⁹ Hong Kong Center for Neurodegenerative Diseases Clear Water Bay Hong Kong China.

No abstract available

Publication types